StonvexLoading…
StonvexStonvexStonvexCore line items from RS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.29B | $13.84B | $14.81B | $17.02B |
Operating Income | $1.01B | $1.16B | $1.74B | $2.51B |
Net Income | $739.40M | $875.20M | $1.34B | $1.84B |
EPS (Diluted) | $13.98 | $15.56 | $22.64 | $29.92 |
Total Assets | $10.37B | $10.02B | $10.48B | $10.33B |
Total Liabilities | $3.19B | $2.79B | $2.75B | $3.23B |
Cash & Equivalents | $216.60M | $318.10M | $1.08B | $1.17B |
Free Cash Flow OCF − CapEx | $502.50M | $999.20M | $1.20B | $1.78B |
Shares Outstanding | 51.73M | 53.72M | 57.27M | 58.79M |